Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/CHUGAI-PHARMACEUTICAL-CO--6491165/news/CHMP-Recommends-EU-Approval-of-Chugai-s-Actemra-RoActemra-to-Treat-Patients-with-Severe-COVID-19-37243603/?utm_source=whatsapp&utm_medium=social&utm_campaign=share